Cancer Management in Man: Biological Response Modifiers, Chemotherapy, Antibiotics, Hyperthermia, Supporting Measures (Cancer Growth and Progression #10).

Paul V. Woolley .

ISBN 10: 0898389992 / ISBN 13: 9780898389999

Published by Kluwer Academic Publishers, 1989

About this Item

Very large glossy purple hardcover, 1989, 248pp. Like new. **OVERSIZE - overseas orders may require additional shipping. **We are a small family business with over 25 years experience providing fine new and pre-owned books online. You can expect professional service and individual attention to your order, daily shipments, and sturdy packaging.

Seller Inventory # 69930

Bibliographic Details

• Title: Cancer Management in Man: Biological Response Modifiers, Chemotherapy, Antibiotics, Hyperthermia, Supporting Measures (Cancer Growth and Progression #10).
• Publisher: Kluwer Academic Publishers
• Publication Date: 1989
• Language: English
• ISBN 10: 0898389992
• ISBN 13: 9780898389999
• Binding: Hardcover
• Condition: Used, like new
• Seller catalogs:
  • Medical

About this title

Synopsis

This volume, the last in this series on cancer growth and Moreover, the current status of plant-derived vinca alka­ progression, is a companion volume to Volume IX and loids and non-alkaloid natural products is summarized. further explores established and novel approaches for the Advances in hyperthermia and additional approaches for therapy of patients with malignant neoplasms. The stra­ the therapy of malignancies are also presented. tegies reflected in these volumes are direct extrapolations The volume continues with chapters on bone marrow from the basic science of cancer biology, growth and pro­ transplantation as well as hematologic and nutritional sup­ gression described in earlier volumes of this series. Some port for the cancer patient. Blood pressure in the cancer approaches are directed towards the eradication or modifi­ patient, therapy for nausea and vomiting as well as pain are cation of the properties of heterogeneous malignant tumor discussed. The last chapter is devoted to the problems of the cells at various stages of tumor progression, while other terminally ill, including evaluations of the burden relatives approaches are directed towards modification of the host and friends of the cancer patient have to bear. antitumor defense systems, e. g. , enhancement of host anti­ It is clear that important advances in the basic science of tumor immune reactivity.